Anne B Leuppi-Taegtmeyer (Anne Leuppi-Taegtmeyer)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Combination Therapy

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Boesing, Claudia Gregoriano, Anna E Minder, Christian Abshagen, Sylwia Dahl, Thomas Dieterle, Frank Eicher, Anne B Leuppi-Taegtmeyer, Luana Rageth, David Miedinger, Elina Wirz, Joerg Daniel Leuppi
Predictors for Unplanned Readmissions within 18 Days after Hospital Discharge: a Retrospective Cohort Study. Praxis 112 (2) (2023)
Tarun Mehra, Kanchan Dongre, Maria Boesing, Patricia Frei, Claudia Suenderhauf, Alfred Zippelius, Joerg D Leuppi, Andreas Wicki, Anne B Leuppi-Taegtmeyer
Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities. Cancer medicine (2023)
Tarun Mehra, Kanchan Dongre, Maria Boesing, Patricia Frei, Claudia Suenderhauf, Alfred Zippelius, Joerg D Leuppi, Andreas Wicki, Anne B Leuppi-Taegtmeyer
Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities. Cancer medicine (2023)
Tarun Mehra, Kanchan Dongre, Maria Boesing, Patricia Frei, Claudia Suenderhauf, Alfred Zippelius, Joerg D Leuppi, Andreas Wicki, Anne B Leuppi-Taegtmeyer
Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities. Cancer medicine (2023)
Tarun Mehra, Kanchan Dongre, Maria Boesing, Patricia Frei, Claudia Suenderhauf, Alfred Zippelius, Joerg D Leuppi, Andreas Wicki, Anne B Leuppi-Taegtmeyer
Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities. Cancer medicine (2023)
Kanchan Dongre, Anja Jungo, Selina Späni, Yvonne Zysset, Anne B Leuppi-Taegtmeyer
Disease-Drug Interactions Requiring Special Attention. Praxis 111 (12) (2022)